Skip to content

Lariva Business

Lariva Blog

Menu
  • Privacy Policy
  • Tech Sharing
  • animate sharing
  • Science Sharing
  • Happening
Menu

Nautilus Biotechnology stock price soars 50% on Amazon investment news

Posted on August 6, 2021 by William
Sujal Patel, co-founder of Nautilus Biotechnology. (Nautilus photo)

Shares Nautilus Biotechnology After a report showed that Amazon acquired the stake in the newly listed Seattle company, the stock price rose by 50% on Thursday morning.

Nautilus, founded in 2016 by the co-founders of Isilon Systems Suhar Patel And the Institute of Systems Biology alum Palag Malik, It is seeking to accelerate biomedical research and transform drug development by developing a new method to analyze the proteome (proteome in biological samples).

In the regulatory document on June 30, Amazon disclosed that it owned 1.46 million shares of Nautilus, which were valued at $14.7 million at the time, as CNBC first reported on Thursday morning.

After the news came out, Nautilus’ stock price climbed from US$7.51 to US$11.30, and then trading in the stock was suspended. As of press time, the stock was 8.65, up 15% on the day.

Amazon has launched various healthcare plans in recent years, but it is unclear whether or how its Nautilus investments fit in with its own plans.

Bezos Expeditions, the venture capital arm of Amazon founder Jeff Bezos, is one of Nautilus investors, which merged with a special purpose acquisition company (SPAC) in June Listed.

Recent Posts

  • Ninja Saga Ultimate Showdown Codes | All New Gift Codes Wiki
  • It is reported that Musk has established artificial intelligence company X.AI and will compete with Open AI
  • F5 About 100 jobs will be cut due to the “current macroeconomic environment”
  • Neoriver decoration lights up Christmas
  • Naveen Jain’s microbiome and diagnostics startup Viome is raising more money
©2025 Lariva Business | Design: Newspaperly WordPress Theme